Kohle-Pulvis (Charcoal, Activated)

Activated charcoal works by providing a highly porous carbon surface that adsorbs a broad spectrum of organic molecules. When taken orally, it binds toxins, drugs, and gases in the gastrointestinal tract, forming complexes that are poorly absorbed and are eliminated in the feces, thereby decreasing systemic toxicity.

The dose of Kohle-Pulvis is individualized and determined by the prescribing clinician based on the type and amount of toxin ingested, the time elapsed since ingestion, and the patient’s clinical condition. Healthcare professionals calculate the appropriate amount to achieve effective decontamination.

Safety data for activated charcoal in pregnancy and lactation are limited. Because it is not systemically absorbed, it is generally considered low risk, but the potential benefits and uncertainties should be weighed by the prescriber. Consultation with a healthcare professional is essential before use.

To order Kohle-Pulvis, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team will then provide pricing, availability, shipping details and any required import documentation.

Compared with alternatives such as gastric lavage or other adsorbents, activated charcoal offers a non‑invasive, rapid means of binding many toxins without the need for instrumentation. It is generally well tolerated, but its efficacy depends on timely administration and may be limited for substances that are not adsorbed, such as metals or acids.

Kohle-Pulvis should be stored at ambient temperature, below 25 °C, in its original container to protect it from moisture and humidity. Keep the product away from direct sunlight and ensure the packaging remains sealed until use to maintain its adsorptive capacity.

Kohle-Pulvis is supplied as a fine powder that is mixed with water or another suitable liquid to form a slurry. The mixture is then ingested orally, usually under medical supervision, to ensure the correct dose is delivered and to minimize the risk of aspiration.

The most serious risks include aspiration of the powder, which can cause respiratory complications, and intestinal obstruction from accumulated charcoal mass. Rarely, severe allergic reactions or significant electrolyte disturbances may occur, particularly with large or repeated doses.

Kohle-Pulvis should be avoided in patients with a compromised airway or who are at high risk of aspiration, as well as in individuals with known hypersensitivity to activated charcoal. It is also contraindicated when the ingested substance is not adsorbed by charcoal, such as certain acids, alkalis, or heavy metals.